Thursday, 2 May 2019

FDA grants breakthrough device designation to KidneyIntelX™

(The Mount Sinai Hospital / Mount Sinai School of Medicine) Provides priority regulatory review of AI-enabled diagnostic for fast-progressing kidney disease

from EurekAlert! - Social and Behavioral Science http://bit.ly/2IXC3sb

No comments:

Post a Comment